Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-6480

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-6480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 01)

FDA Label Image

Figure-02 (Figure 02)

The text is a chart showing the Cumulative Hazard (%) for Atorvastatin over a period of four years of follow-up. The hazard ratio (HR) suggests a decreased risk with a value of 0.53 and confidence interval of (0.45-0.83). The chart also includes time increments from 1-5 years.*

FDA Label Image

Figure-03 (Figure 03)

This text represents the results of a clinical trial comparing the effectiveness of two cholesterol-lowering drugs, Horvastatin 10 mg and Sorvastatin 80 mg, in reducing the risk of major cardiovascular events. The data presented indicates that Horvastatin is associated with a lower risk compared to Sorvastatin, with a hazard ratio of 0.78. The significance level of the result is also provided (p=0.0002). The graph shows the time to the first major cardiovascular event over a four-year follow-up period.*

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Label Image (Lbl500906480)

This is a description of a medication called "ATORVASTATIN" with the corresponding prescription number of "9532-0" and a calcium content of 16 HG. The medication is in tablet form with a quantity of 90 tablets and can be found at the location listed as "STonE AT 6870 7 DeGages ¢."*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.